Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases

NCT02755428 is registered in ClinicalTrials.gov with Chinese Academy of Sciences as lead sponsor.

NCT NCT02755428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02755428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases
Lead sponsor
Chinese Academy of Sciences
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2018
Completion date
December 31, 2020
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry age-related macular degeneration